Updating FDA regulations for cosmetics manufacturing this year could be linked to legislation on establishing a user fee program to pay for improving its OTC drug monograph program, according to members of the House committee with oversight of the agency.
Cosmetic Regulation Update's Link With OTC Drug User Fees Clear At Hearing
Members of the House Health Subcommittee suggest their support for potential OTC monograph reform legislation depends on including provisions that would add substantial details to FDA's oversight of cosmetics manufacturers and a related user fee program.